Efficient production of adeno-associated virus vectors using split-type helper plasmids

Japanese Journal of Cancer Research

Volumn 90, Issue 4, 1999, Pages 476-483

  Ogasawara, Yoji ^a,b,c   Urabe, Masashi ^a,b   Kogure, Katsuhiro ^a,b   Kume, Akihiro ^a,b   Colosi, Peter ^d   Kurtzman, Gary J ^d   Ozawa, Keiya ^a,b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Avigen Inc   (United States)

Author keywords

AAV vector; Cap; Gene therapy; Helper plasmid; Rep

Indexed keywords

HELICASE; VIRUS PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA PACKAGING; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0032903640     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00772.x     Document Type: Article

References (32)

1. Carter, B. J. The growth cycle of adeno-associated virus. In "Handbook of Parvoviruses," vol. I, ed. P. Tjissen, pp. 155-168 (1990). CRC Press, Boca Raton, FL.
2. Carter, B. J., Mendelson, E. and Trempe, J. P. AAV DNA replication, integration and genetics. In "Handbook of Parvoviruses," vol. I, ed. P. Tjissen, pp. 169-226 (1990). CRC Press, Boca Raton, FL.
3. Flotte, T. R. and Carter, B. J. Adeno-associated virus vectors for gene therapy. Gene Ther., 2, 357-362 (1995).
4. Blacklow, N. R., Hoggan, M. D., Kapikian, A. Z., Austin, J. B. and Rowe, W.P. Epidemiology of adeno-associated virus infection in a nursery population. Am. J. Epidemiol., 8, 368-378 (1968).
5. Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B. and Carter, B. J. Stable in vivo expression of the cystic fibrosis transmembrane regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA, 90, 10613-10617 (1993).
6. Kaplit, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O'Mally, K. L. and During, M. J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet., 8, 148-153 (1994).
7. Podsakoff, G., Wong, K. K. and Chaterjee, S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol., 68, 5656-5666 (1994).
8. Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P., Matelis, L. A., Kurtzman, G. J. and Byrne, B. J. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of therapeutic protein. Proc. Natl. Acad. Sci. USA, 93, 14082-14087 (1996).
9. Srivastava, A., Lusby, E. W. and Berns, K. I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol., 45, 555-564 (1983).
10. Hermonat, P. L., Labow, M. A., Wright, R., Berns, K. I. and Muzyczka, N. Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J. Virol., 51, 329-339 (1984).
11. Tratschin, J. D., Miller, I. L. and Carter, B. J. Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J. Virol., 51, 611-618 (1984).
12. Surosky, R. T., Urabe, M., Godwin, S. G., McQuiston, S. A., Kurtzman, G. J., Ozawa, K. and Natsoulis, G. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol., 71, 7951-7959 (1997).
13. Chejanovsky, N. and Carter, B. J. Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication. Virology, 173, 120-128 (1989).
14. Pereira, D. J., McCarty, D. M. and Muzyczka, N. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J. Virol., 71, 1079-1088 (1997).
15. Janik, J. E., Huston, M. M. and Rose, J. A. Adeno-associated virus proteins: origin of the capsid components. J. Virol., 52, 591-597 (1984).
16. Becerra, S. P., Koczot, F., Febisch, P. and Rose, J. A. Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J. Virol., 62, 2745-2754 (1988).
17. Kotin, R. M. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther., 5, 793-801 (1994).
18. Chiorini, J. A., Wendtner, C. M., Urcelay, E., Safer, B., Halles, M. and Kotin, R. M. High-efficiency transfer of the T cell costimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther., 6, 1531-1541 (1995).
19. Matsushita, T., Elliger, S., Elliger, C., Podsakoff, G., Villarreal, L., Kurtzman, G. J., Iwaki, Y. and Colosi, P. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther., 5, 938-945 (1998).
20. Xiao, X., Li, J. and Samulski, R. J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol., 72, 2224-2232 (1998).
21. Clark, K. R., Voulgaropoulou, F., Fraley, D. M. and Johnson, P. R. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther., 6, 1329-1341 (1995).
22. Tamayose, K., Hirai, Y. and Shimada, T. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther., 7, 507-513 (1996).
23. Mendelson, E., Smith, M. G., Miller, I. L. and Carter, B. J. Effect of a viral rep gene on transformation of cells by an adeno-associated virus vector. Virology, 166, 612-615 (1988).
24. Graham, F. L., Smiley, J., Russell, W. C. and Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36, 59-74 (1977).
25. McCarty, D. M., Christensen, M. and Muzyczka, N. Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. J. Virol., 65, 2936-2945 (1991).
26. Okada, H., Miyamura, K., Itoh, T., Hagiwara, M., Wakabayashi, T., Mizuno, M., Colosi, P., Kurtzman, G. and Yoshida, J. Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther., 3, 957-964 (1996).
27. Wigler, M., Pellicer, A., Silverstein, S. and Axel, R. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell, 14, 725 (1978).
28. Hölscher, C., Hörer, M., Kleinschmidt, J. A., Zentgraf, H., Bürkle, A. and Heilbronn, R. Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants. J. Virol., 68, 7169-7177 (1994).
29. Im, D. S. and Muzyczka, N. Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J. Virol., 66, 1119-1128 (1992).
30. Allen, J. M., Debelak, D. J., Reynolds, T. C. and Miller, A. D. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J. Virol., 71, 6816-6822 (1997).
31. Vincent, K. A., Piraino, S. T. and Wadsworth, S. C. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol., 71, 1897-1905 (1997).
32. Li, J., Samulski, R. J. and Xiao, X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol., 71, 5236-5243 (1997).